|
시장보고서
상품코드
1986621
의약품용 유리 포장 시장 규모, 점유율, 동향 분석 보고서 : 재료별, 제품별, 의약품별, 지역별, 부문별 예측(2026-2033년)Pharmaceutical Glass Packaging Market Size, Share & Trends Analysis Report By Material (Type I, Type II, Type III), By Product (Vials, Bottles, Ampoules), By Drug (Generic, Branded, Biologic), By Region, And Segment Forecasts, 2026 - 2033 |
||||||
의약품용 유리 포장 시장 요약
세계의 의약품용 유리 포장 시장 규모는 2025년에 234억 달러로 추정되며, 2033년까지 515억 6,000만 달러에 달할 것으로 예측됩니다.
2026년부터 2033년까지 CAGR 10.5%로 성장할 것으로 예상됩니다. 제네릭 주사제의 광범위한 사용과 더불어 제약 업계의 높은 수요가 시장 성장을 견인할 것으로 예상됩니다.
석회석(CaCO3), 소다회(Na2CO3), 유리 조각, 모래(SiO2)가 유리의 전체 화학 성분을 구성합니다. 의약품 포장 응용 분야에서 유리 제품에서 가장 일반적으로 발견되는 양이온은 바륨, 아연, 철, 마그네슘, 칼슘, 칼륨, 칼륨, 나트륨, 붕소, 알루미늄 및 실리콘입니다. 이러한 재료는 내화학성, 경도, 내구성 등 유리의 특성에 영향을 미칩니다.
의료 분야에서 비용에 대한 인식이 높아지고 바이오의약품의 중요성이 커지면서 약물전달 제품에 대한 엄격한 규제가 시행되고 있습니다. 제약용 유리 제조 업계의 많은 제조업체들은 제품의 유통기한을 연장하기 위한 포장에 초점을 맞추고 있으며, 이를 위해 바이알에 투자하고 있습니다.
의약품용 유리 포장 개발 기업들은 변화하는 제약 산업에 대응하기 위해 제품 기능 개선에 힘쓰고 있으며, 이는 미국 시장 성장을 더욱 촉진할 수 있습니다. 예를 들어, 2023년 11월, 코닝은 '코닝 속도 바이알'로 알려진 특수 코팅이 적용된 타입 I 붕규산 유리 바이알을 출시하였습니다. 이 바이알은 기존의 붕규산 유리 바이알에 비해 높은 경도를 보여 균열이나 파손의 가능성을 줄여줍니다.
유리는 이산화탄소, 산소 등 대기 중 가스가 의약품의 1차 유리 용기 내부로 침입하는 것을 방지하는 장벽이 되어 의약품의 오염 위험을 줄입니다. 유리 포장은 가수분해, 산화 등의 열화에 대한 의약품의 민감성을 감소시킵니다. 또한, 유리 포장은 휘발성 성분의 유출을 방지하여 의약품의 안정성을 높이는 데 도움이 됩니다. 이러한 모든 요인으로 인해 가까운 시일 내에 제품 수요가 급증할 것으로 예상됩니다.
의약품용 유리 포장 산업은 괄목할만한 성장과 혁신의 기세가 높아지고 있습니다. 재활용이 가능한 특성과 더불어 지속가능성 및 친환경 포장 솔루션에 대한 업계의 관심이 높아짐에 따라 유리는 매력적인 대안으로 자리매김하고 있으며, 이는 지속가능성에 대한 제약사의 노력에 부합하는 것으로 평가받고 있습니다. RFID 태그, 변조 방지 기능 등 스마트 포장 기술을 통합하여 의약품용 유리 포장의 매력과 기능성을 향상시킵니다. 의약품 포장에 대한 규제 강화에 대응하여 독창적이고 규정을 준수하며 비용 효율적인 유리 포장 솔루션을 제공하는 제조업체는 큰 시장 점유율을 확보할 수 있는 유리한 위치에 있습니다.
자주 묻는 질문
목차
제1장 분석 방법·범위
제2장 주요 요약
제3장 세계의 의약품용 유리 포장 시장 : 변수, 동향, 범위
제4장 의약품용 유리 포장 시장 : 가격 동향 분석
제5장 의약품용 유리 포장 시장 : 재료별 추정·동향 분석
제6장 의약품용 유리 포장 시장 : 제품별 추정·동향 분석
제7장 의약품용 유리 포장 시장 : 의약품별 추정·동향 분석
제8장 의약품용 유리 포장 시장 : 지역별 추정·동향 분석
제9장 경쟁 구도
제10장 상장 기업 리스트/기업 개요
KSM 26.04.28Pharmaceutical Glass Packaging Market Summary
The global pharmaceutical glass packaging market size was estimated at USD 23.40 billion in 2025 and is projected to reach USD 51.56 billion by 2033, growing at a CAGR of 10.5% from 2026 to 2033. Extensive utilization of generic injectable drugs coupled with high demand from the pharmaceutical industry is anticipated to drive market growth.
Limestone (CaCO3), soda ash (Na2CO3), cullet, and sand (SiO2) comprise the overall chemical composition of glass. For pharmaceutical packaging applications, the most common cations found in glassware are barium, zinc, ferrous, magnesium, calcium, potassium, sodium, boron, aluminum, and silicon. These materials influence the properties of glass such as chemical resistance, hardness, and durability.
The growing significance of cost-sensitivity and biotech drugs in the healthcare sector has resulted in the establishment of strict regulations related to the drug delivery products. Multiple manufacturers working in pharmaceutical glass manufacturing industry are focused on packaging aimed at increasing shelf life of a product and are therefore investing in vials.
Pharmaceutical glass packaging developers have been enhancing their product capabilities to cater to the changing pharmaceutical industry, which can further contribute to the market growth in the U.S. For instance, in November 2023, Corning Incorporated introduced coated specially engineered Type I borosilicate vials known as Corning Velocity Vials. These vials exhibit effective hardness compared to conventional borosilicate vials, reducing the probability of cracking and breaking.
Glass poses as a hindrance to atmospheric gases such as carbon dioxide and oxygen from entering the primary pharmaceutical glass container, mitigating the risk of contamination of the drugs. Glass packaging lowers the susceptibility of drugs to degradation, such as hydrolysis and oxidation. Moreover, glass packaging helps in resisting escape of volatile ingredients, thereby increasing the drug stability. All these factors are anticipated to surge the product demand in near future.
The pharmaceutical glass packaging industry is poised for significant growth and innovation. Given its recyclable nature, the industry's increasing focus on sustainability and environmentally friendly packaging solutions positions glass as an attractive choice, which aligns well with pharmaceutical companies' heightened emphasis on sustainable practices. Integrating intelligent packaging technologies, such as RFID tags and tamper-evident features, enhances the appeal and functionality of pharmaceutical glass packaging. In response to tightening regulations on pharmaceutical packaging, manufacturers that offer inventive, compliant, and cost-effective glass packaging solutions are well-positioned to capture substantial market share.
Global Pharmaceutical Glass Packaging Market Report Segmentation
This report forecasts revenue growth at a global level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global pharmaceutical glass packaging market report based on material, product, drug, material, and region:
- Material Outlook (Volume, Million Units; Revenue, USD Million, 2021 - 2033)
- Type I
- Type II
- Type III
- Product Outlook (Volume, Million Units; Revenue, USD Million, 2021 - 2033)
- Vials
- Small vials
- Large vials
- Bottles
- Small bottles
- Large bottles
- Cartridges & Syringes
- Ampoules
- Drug Outlook (Volume, Million Units; Revenue, USD Million, 2021 - 2033)
- Generic
- Branded
- Biologic
- Regional Outlook (Volume, Million Units; Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- Latin America
- Brazil
- Middle East & Africa
- Saudi Arabia
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Research Methodology
- 1.1.1. Market Segmentation
- 1.1.2. Market Definition
- 1.2. Research Scope & Assumptions
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources & Third-Party Perspectives
- 1.3.4. Primary Research
- 1.4. Information Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Formulation & Data Visualization
- 1.6. Data Validation & Publishing
- 1.7. List of Abbreviations
Chapter 2. Executive Summary
- 2.1. Market Snapshot, 2024 (USD Million)
- 2.2. Segmental Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Global Pharmaceutical Glass Packaging Market Variables, Trends, and Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Marke Outlook
- 3.2. Industry Value Chain Analysis
- 3.2.1. Raw Material Trends
- 3.2.2. Manufacturing/Technology Trends
- 3.2.3. Sales Channel Analysis
- 3.3. Regulatory Framework
- 3.4. Market Dynamics
- 3.4.1. Market Driver Analysis
- 3.4.2. Market Restraint Analysis
- 3.4.3. Market Opportunity Analysis
- 3.4.4. Market Challenge Analysis
- 3.5. Business Environment Analysis
- 3.5.1. Porter's Five Forces Analysis
- 3.5.2. PESTEL Analysis
- 3.6. Impact of Environmental, Social, and Governance (ESG) initiatives on the Pharmaceutical Glass Packaging Market
- 3.6.1. Market Differentiation
- 3.6.2. Regulatory Compliance
- 3.6.3. Industry Collaboration
- 3.6.4. Enhanced Brand Value
- 3.6.5. Addressing Consumer Demands
Chapter 4. Pharmaceutical Glass Packaging Market: Price Trend Analysis
- 4.1. Pricing Trend Analysis, by Material, 2021 - 2033 (USD/Units)
- 4.2. Factors Affecting the Pricing Deviation
Chapter 5. Pharmaceutical Glass Packaging Market: Material Estimates & Trend Analysis
- 5.1. Definition & Scope
- 5.2. Material Movement Analysis & Market Share, 2025 & 2033
- 5.3. Type I
- 5.3.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 5.4. Type II
- 5.4.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 5.5. Type III
- 5.5.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
Chapter 6. Pharmaceutical Glass Packaging Market: Product Estimates & Trend Analysis
- 6.1. Definition & Scope
- 6.2. Product Movement Analysis & Market Share, 2025 & 2033
- 6.3. Vials
- 6.3.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 6.4. Bottles
- 6.4.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 6.5. Cartridges & Syringes
- 6.5.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 6.6. Ampoules
- 6.6.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
Chapter 7. Pharmaceutical Glass Packaging Market: Drug Estimates & Trend Analysis
- 7.1. Definition & Scope
- 7.2. Drug Movement Analysis & Market Share, 2025 & 2033
- 7.3. Generic
- 7.3.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 7.4. Branded
- 7.4.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 7.5. Biologic
- 7.5.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
Chapter 8. Pharmaceutical Glass Packaging Market: Regional Estimates & Trend Analysis
- 8.1. Key Takeaways
- 8.2. Regional Movement Analysis & Market Share, 2025 & 2033
- 8.3. North America
- 8.3.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.3.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.3.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.3.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.3.5. U.S.
- 8.3.5.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.3.5.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.3.5.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.3.5.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.3.6. Canada
- 8.3.6.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.3.6.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.3.6.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.3.6.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.3.7. Mexico
- 8.3.7.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.3.7.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.3.7.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.3.7.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.4. Europe
- 8.4.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.4.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.4.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.4.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.4.5. Germany
- 8.4.5.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.4.5.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.4.5.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.4.5.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.4.6. UK
- 8.4.6.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.4.6.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.4.6.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.4.6.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.4.7. Italy
- 8.4.7.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.4.7.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.4.7.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.4.7.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.4.8. Spain
- 8.4.8.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.4.8.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.4.8.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.4.8.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.5. Asia Pacific
- 8.5.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.5.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.5.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.5.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.5.5. China
- 8.5.5.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.5.5.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.5.5.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.5.5.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.5.6. India
- 8.5.6.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.5.6.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.5.6.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.5.6.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.5.7. Japan
- 8.5.7.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.5.7.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.5.7.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.5.7.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.5.8. South Korea
- 8.5.8.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.5.8.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.5.8.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.5.8.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.5.9. Australia
- 8.5.9.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.5.9.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.5.9.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.5.9.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.6. Central & South America
- 8.6.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.6.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.6.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.6.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.6.5. Brazil
- 8.6.5.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.6.5.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.6.5.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.6.5.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.7. Middle East & Africa
- 8.7.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.7.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.7.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.7.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.7.5. Saudi Arabia
- 8.7.5.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.7.5.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.7.5.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.7.5.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Key Global Players & Recent Developments & Their Impact On the Industry
- 9.2. Key Company/Competition Categorization (Key innovators, Market leaders, emerging players)
- 9.3. List of key Raw Material Distributors and Channel Partners
- 9.4. List of Potential Customers, by End-use
- 9.5. Company Heat Map Analysis
- 9.6. Competitive Dashboard Analysis
- 9.7. Strategy Mapping
- 9.7.1. Capacity Expansion
- 9.7.2. Collaboration/ Partnerships/ Agreements
- 9.7.3. New Product launches
- 9.7.4. Mergers & Acquisitions
- 9.7.5. Innovation in Technology/ Material
- 9.7.6. Others
Chapter 10. Company Listing / Profiles
- 10.1. Corning Incorporated
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.2. Nipro Corporation
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.3. SGD S.A.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.4. Stolzle-Oberglas GmbH
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.5. West Pharmaceutical Services, Inc.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.6. Schott AG
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.7. Gerresheimer AG
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.8. Bormioli Pharma S.r.l
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.9. Shandong Medicinal Glass Co., Ltd.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.10. Beatson Clark
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.11. Ardagh Group S.A.
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.12. Arab Pharmaceutical Glass Co.
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.13. Piramal Enterprises Ltd.
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.14. Sisecam Group
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.15. Owens-Illinois, Inc
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.16. DWK Life Sciences
- 10.16.1. Company Overview
- 10.16.2. Financial Performance
- 10.16.3. Product Benchmarking
